LLY

1,096.53

-1.32%↓

JNJ

228.19

-2.26%↓

ABBV

216.7

-2.01%↓

UNH

400.27

+0.24%↑

NVS

146.82

-2.48%↓

LLY

1,096.53

-1.32%↓

JNJ

228.19

-2.26%↓

ABBV

216.7

-2.01%↓

UNH

400.27

+0.24%↑

NVS

146.82

-2.48%↓

LLY

1,096.53

-1.32%↓

JNJ

228.19

-2.26%↓

ABBV

216.7

-2.01%↓

UNH

400.27

+0.24%↑

NVS

146.82

-2.48%↓

LLY

1,096.53

-1.32%↓

JNJ

228.19

-2.26%↓

ABBV

216.7

-2.01%↓

UNH

400.27

+0.24%↑

NVS

146.82

-2.48%↓

LLY

1,096.53

-1.32%↓

JNJ

228.19

-2.26%↓

ABBV

216.7

-2.01%↓

UNH

400.27

+0.24%↑

NVS

146.82

-2.48%↓

Search

Thermo Fisher Scientific Inc

Fechado

SetorSaúde

464.64 0.93

Visão Geral

Variação de preço das ações

24h

Atual

Mín

464.64

Máximo

467.51

Indicadores-chave

By Trading Economics

Rendimento

-314M

1.7B

Vendas

-1.2B

11B

P/E

Médio do Setor

26.043

49.712

EPS

5.44

Rendimento de Dividendos

0.38

Margem de lucro

15.048

Funcionários

125,000

EBITDA

-905M

2.3B

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+28.05% upside

Dividendos

By Acuity

Rendimento de Dividendos

Médio do Setor

0.38%

2.36%

Próximos Ganhos

22 de jul. de 2026

Próxima data de dividendos

15 de jul. de 2026

Próxima data de ex-dividendo

14 de set. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-19B

176B

Abertura anterior

463.71

Fecho anterior

464.64

Sentimento de Notícias

By Acuity

36%

64%

82 / 342 Ranking em Healthcare

Thermo Fisher Scientific Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Sobre Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquar
help-icon Live chat